These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 29230817)

  • 1. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
    Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
    J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.
    Zhou X; Zheng J; Tang Y; Lin Y; Wang L; Li Y; Liu C; Wu D; Cai L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31471531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
    Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
    Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.
    Hsu CY; Yi YH; Chang KP; Chang YS; Chen SJ; Chen HC
    PLoS Pathog; 2014 Feb; 10(2):e1003974. PubMed ID: 24586173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
    Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
    Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
    Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
    Cai L; Li J; Zhang X; Lu Y; Wang J; Lyu X; Chen Y; Liu J; Cai H; Wang Y; Li X
    Oncotarget; 2015 Apr; 6(10):7838-50. PubMed ID: 25691053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
    Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
    J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy.
    Lung RW; Tong JH; To KF
    Int J Mol Sci; 2013 Aug; 14(9):17378-409. PubMed ID: 23979421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
    Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
    Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.